Biotech IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants June 9, 2026
Biotech Curasight Announces Preliminary Readout from its Phase 1 Clinical Trial with uTREAT® in Aggressive Brain Cancer (Glioblastoma) June 8, 2026
Biotech Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association’s 2026 Scientific Sessions June 7, 2026
Biotech SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver June 6, 2026
Biotech Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026 June 3, 2026
Biotech Genomics Launches the Mystra AI Platform, Adopted by Industry Giants and Up-and-Coming Biotechs June 2, 2026
Biotech LUCENT Appoints Simon Doyle as CEO with Matthew Goodman Taking Chief Medical Officer Position June 1, 2026
Biotech Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026 May 31, 2026